Revaprazan is a potassium-competitive acid blocker used clinically to treat conditions such as gastritis, gastroesophageal reflux disease, and peptic ulcer disease by suppressing gastric acid secretion… Read more













Revaprazan is a potassium-competitive acid blocker used clinically to treat conditions such as gastritis, gastroesophageal reflux disease, and peptic ulcer disease by suppressing gastric acid secretion via H+/K+-ATPase inhibition. Our catalog includes high-quality reference standards of the Revaprazan API alongside a comprehensive selection of its pharmacopeial and non-pharmacopeial impurities, including stereoisomers and N-nitroso derivatives. Additionally, we provide stable isotope labelled compounds to support advanced analytical testing. These reference materials are essential for pharmaceutical laboratories engaged in rigorous impurity profiling, method validation, and ongoing quality control. By utilizing these precisely characterized standards and labelled internal standards, researchers can ensure accurate quantification and regulatory compliance during the development and manufacturing of this gastrointestinal medication.